Is There Still Room To Run For These Biotech Stocks?

Biotechnology companies' fortunes depend on binary events, such as FDA approvals and clinical trials results. However, capitalizing on these opportunities depends on knowing when the key events are going to happen. The returns can be impressive when the stocks are bought and sold at the right time.

from RTT - Biotech https://ift.tt/2LVui33
via IFTTT